AI assistant
LifeMD, Inc. — Director's Dealing 2021
Apr 29, 2021
33298_dirs_2021-04-29_753e57f5-8b15-4315-9eae-2f1290cc2b93.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3/A — Form 3/A
Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2021-02-03
Reporting Person: Deutsch Corey (Chief Business Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 48630 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Options to purchase shares of Common Stock | $ | Common Stock, par value $0.001 (25000) | Direct | ||
| Options to purchase shares of Common Stock | $ | Common Stock, par value $0.001 (175000) | Direct |
Footnotes
F1: This Form 3 amendment is being filed to correct the number of shares directly owned Mr. Deutsch as of February 3, 2021.
F2: Previously filed Form 3/A on April 29, 2021 was erroneously filed with a scriveners error related to the date Mr. Deutsch purchased such shares. The shares were purchased by Mr. Deutsch on November 19, 2020, in a private placement offering by the Company.
F3: On February 3, 2021 (the "Effective Date"), Mr. Deutsch and the Issuer entered into First Amendment to Employment Agreement (the "Amended Employment Agreement"), whereby Mr. Deutsch was appointed Chief Business Officer of the Issuer. As of the Effective Date, the Board of Directors of the Issuer has acknowledged the role of Chief Business Officer as an executive officer position.
F4: Pursuant to the terms of the consulting agreement, by and between Mr. Deutsch and the Issuer, dated December 3, 2020, Mr. Deutsch was granted stock options to purchase up to 25,000 shares of the Company's common stock at an exercise price of $8.25 per share (the "Consultancy Stock Options"). The Consultancy Stock Options vested on December 3, 2020.
F5: Pursuant to the terms of the employment agreement, by and between Mr. Deutsch and the Issuer, dated January 14, 2021, Mr. Deutsch was granted stock options to purchase up to 175,000 shares of the Company's common stock at an exercise price of $7.07 per share (the "Stock Options"). The Stock Options shall vest in equal monthly tranches, based on the passage of time, over the 36 months, beginning on the Effective Date.